Cellectis Stock Forum

$Cellectis(CLLS.US)$
NEWS
Cellectis Publishes a Novel Intronic Gene Editing Approach For the Treatment of Inborn Metabolic Diseases by Edited HSPCs
Cellectis (NASDAQ: CLLS) announces a breakthrough in gene-editing therapy with the publication of a new research paper. The study demonstrates the potential of TALEN-mediated intron editing in HSPCs for targeted transgene expression, offering new treatment possibilities for metabolic and neurological diseases.

$Cellectis(CLLS.US)$ Cellectis Publishes a Novel Intronic Gene Editing Approach For the Treatment of Inborn Metabolic Diseases by Edited HSPCs
3 MINUTES AGO, 4:30 PM EDT
VIA GLOBENEWSWIRE
NEW YORK, April 10, 2024 (GLOBE NEWSWIRE) -- Cellectis (the "Company") (NASDAQ:CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, announced today the publication of a new research paper in Molecular Therapy, demonstrating that...

$Cellectis(CLLS.US)$ Cellectis Announces The Execution Of The Subsequent $140M Equity Investment Agreement With AstraZeneca

$Cellectis(CLLS.US)$ reported quarterly losses of $(0.36) per share which beat the analyst consensus estimate of $(0.42) by 14.29 percent. This is a 37.93 percent increase over losses of $(0.58) per share from the same period last year. The company reported quarterly sales of $1.64 million which missed the analyst consensus estimate of $3.58 million by 54.08 percent. This is a 14.42 percent decrease over sales of $1.92 million the same period last year.

$Cellectis(CLLS.US)$ loading zone first 🎯 $5 then $35 🎯

$Cellectis(CLLS.US)$ break 3.39 for 3.53 then 3.8s and ill be looking for 52 week high. might be a swing play